A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.
Bot I, Ortiz Zacarías NV, de Witte WE, de Vries H, van Santbrink PJ, van der Velden D, Kröner MJ, van der Berg DJ, Stamos D, de Lange EC, Kuiper J, IJzerman AP, Heitman LH.
Bot I, et al. Among authors: de witte we, de vries h, de lange ec.
Sci Rep. 2017 Mar 3;7(1):52. doi: 10.1038/s41598-017-00104-z.
Sci Rep. 2017.
PMID: 28246398
Free PMC article.